Fleeting popularity

Fleeting popularity

When the CFOs attending the Association of Bioscience Financial Officers annual meeting in San Francisco assembled to hear representatives of the national media last week, the message was - in a word - a bummer. The correspondents from Business Week, The Wall Street Journal and The New York Times all related versions of the same message: Vanishing space for biotech stories, fewer reporters covering the industry and dwindling interest on the part of their editors.

BioCentury, represented by its publisher,

Read the full 810 word article

How to gain access

Continue reading with a
two-week free trial.